ACRS:NASDAQ, Aclaris Therapeutics, Inc.

ACRS stock overview

Aclaris Therapeutics, Inc. (ACRS:NASDAQ) closed at $3.92 on November 13, 2026, down 2.00% on the day. The stock trades 40.6% below its 52-week high of $6.60 and 74.2% above its 52-week low of $2.25. Over the past year, it gained 55.6%. Aclaris Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price: $3.92
Day change: -2.00%
Volume: 1,146,560
Average volume: 2,888,501
Market cap: 621M+
52-week range: $2.25 – $6.60
50-day average: $4.47
200-day average: $4.54

Price action over the past year

In 252 trading sessions since November 13, 2025, ACRS closed higher on 122 days (48%). Its best day was January 20, 2026 (+69.08%) and its worst was October 1, 2026 (-16.16%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

Nov 5, 2026: News catalyst: Earnings (News Catalysts scanner)
Oct 1, 2026: Dropped 16.2% in a single session (Dips & Crashes scanner)

ACRS news

Nov 12, 2026: Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference
Nov 6, 2026: Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year?
Nov 5, 2026: Aclaris Therapeutics (ACRS) Reports Q3 Loss, Beats Revenue Estimates
Nov 5, 2026: Aclaris: Q3 Earnings Snapshot
Nov 5, 2026: Aclaris Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate and Clinical Update
Oct 27, 2026: Aclaris Therapeutics ATI-052 Posts Early Eczema, Asthma Signals in Phase 1b
Oct 27, 2026: Aclaris Therapeutics Reports Positive Phase 1b ATI-052 Trial Results, Prices $50 Million Offering
Oct 27, 2026: Aclaris Reports Positive Asthma, Eczema Drug Trial Results — So, Why Is ACRS Stock Down Nearly 8%?

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

Similar stocks

Find more stocks like ACRS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.